BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31487268)

  • 1. Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity.
    Katsuyama T; Li H; Comte D; Tsokos GC; Moulton VR
    J Clin Invest; 2019 Dec; 129(12):5411-5423. PubMed ID: 31487268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing factor SRSF1 controls distinct molecular programs in regulatory and effector T cells implicated in systemic autoimmune disease.
    Cassidy MF; Herbert ZT; Moulton VR
    Mol Immunol; 2022 Jan; 141():94-103. PubMed ID: 34839165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing factor SRSF1 limits IFN-γ production via RhoH and ameliorates experimental nephritis.
    Katsuyama T; Li H; Krishfield SM; Kyttaris VC; Moulton VR
    Rheumatology (Oxford); 2021 Jan; 60(1):420-429. PubMed ID: 32810232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus.
    Katsuyama T; Martin-Delgado IJ; Krishfield SM; Kyttaris VC; Moulton VR
    Rheumatology (Oxford); 2020 Aug; 59(8):2146-2155. PubMed ID: 32206811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitination regulates expression of the serine/arginine-rich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells.
    Moulton VR; Gillooly AR; Tsokos GC
    J Biol Chem; 2014 Feb; 289(7):4126-34. PubMed ID: 24368769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-Induced hsa-miR-10b-5p Is Elevated in T Cells From Patients With Systemic Lupus Erythematosus and Down-Regulates Serine/Arginine-Rich Splicing Factor 1.
    Ramanujan SA; Cravens EN; Krishfield SM; Kyttaris VC; Moulton VR
    Arthritis Rheumatol; 2021 Nov; 73(11):2052-2058. PubMed ID: 33982889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3.
    Cassidy MF; Herbert ZT; Moulton VR
    Mol Immunol; 2022 Dec; 152():140-152. PubMed ID: 36368121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splicing factor SRSF1 is indispensable for regulatory T cell homeostasis and function.
    Katsuyama T; Moulton VR
    Cell Rep; 2021 Jul; 36(1):109339. PubMed ID: 34233194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Expression of Serine/Arginine-Rich Splicing Factor 1 in T Cells From Patients With Active Systemic Lupus Erythematosus Accounts for Reduced Expression of RasGRP1 and DNA Methyltransferase 1.
    Kono M; Kurita T; Yasuda S; Kono M; Fujieda Y; Bohgaki T; Katsuyama T; Tsokos GC; Moulton VR; Atsumi T
    Arthritis Rheumatol; 2018 Dec; 70(12):2046-2056. PubMed ID: 29905030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells.
    Moulton VR; Gillooly AR; Perl MA; Markopoulou A; Tsokos GC
    PLoS One; 2015; 10(7):e0131073. PubMed ID: 26134847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splicing factor SRSF1 is essential for CD8 T cell function and host antigen-specific viral immunity.
    Juarez I; Su S; Herbert ZT; Teijaro JR; Moulton VR
    Front Immunol; 2022; 13():906355. PubMed ID: 36189299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.
    Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y
    EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis.
    Chuang HC; Chen YM; Hung WT; Li JP; Chen DY; Lan JL; Tan TH
    Oncotarget; 2016 Sep; 7(36):57593-57605. PubMed ID: 27557500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WAVE2 suppresses mTOR activation to maintain T cell homeostasis and prevent autoimmunity.
    Liu M; Zhang J; Pinder BD; Liu Q; Wang D; Yao H; Gao Y; Toker A; Gao J; Peterson A; Qu J; Siminovitch KA
    Science; 2021 Mar; 371(6536):. PubMed ID: 33766857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of Treg Cell Differentiation and Function by the Interleukin-21-Mechanistic Target of Rapamycin Axis Via Suppression of Autophagy in Patients With Systemic Lupus Erythematosus.
    Kato H; Perl A
    Arthritis Rheumatol; 2018 Mar; 70(3):427-438. PubMed ID: 29161463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
    Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
    Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity.
    Yi W; Gupta S; Ricker E; Manni M; Jessberger R; Chinenov Y; Molina H; Pernis AB
    Nat Commun; 2017 Aug; 8(1):254. PubMed ID: 28811467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis.
    Caza T; Wijewardena C; Al-Rabadi L; Perl A
    Transl Res; 2022 Jul; 245():55-81. PubMed ID: 35288362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Gαq expression in T cells correlates with enhanced cytokine production and disease activity in systemic lupus erythematosus.
    He Y; Huang Y; Tu L; Luo J; Yu B; Qian H; Duan L; Shi G
    Oncotarget; 2016 Dec; 7(52):85741-85749. PubMed ID: 27965465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.